Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2017

06.09.2017 | Gynecologic Endocrinology and Reproductive Medicine

Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35–40 years undergoing long GnRH agonist IVF/ICSI cycles

verfasst von: Jianjun Zhou, Bin Wang, Yali Hu, Haixiang Sun

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To study the association between the numbers of oocytes retrieved and the cumulative live birth rates (LBR) in women aged 35–40 years undergoing long GnRH agonist IVF/ICSI cycles.

Methods

A total of 931 women aged 35–40 years who underwent their first cycle of IVF/ICSI treatment between January 2010 and December 2013 at Nanjing Drum Tower Hospital were identified and reviewed. The main endpoint of this study was the cumulative LBR after one complete oocyte retrieval, which included fresh and all subsequent frozen–thaw embryo transfer cycles. Odds ratios (OR) and 95% confidence interval (CI) for live birth were estimated by multivariate logistic regression analysis. Furthermore, all the women were divided into four groups based on the number of oocytes retrieved: 0–4, 5–9, 10–14 or ≥15 oocytes group. Variables were then compared among groups.

Results

We found that 634 out of the 931 patients (68.1%) achieved at least one live birth. The number of oocytes retrieved was an independent predictive factor for live birth, with OR 1.20 (95% CI 1.15–1.26) when adjusted for age (years), duration of infertility and Gn (gonadotrophin) doses. The cumulative LBR in the four different oocyte groups was 35.6, 68.8, 83.4 and 89.2%, respectively. When the 1–4 oocytes group was issued as a reference, the ORs for cumulative LBR gradually increased to 3.66, 6.74 and 11.77 in other three oocytes groups, respectively. The moderate–severe ovarian hyperstimulation syndrome (OHSS) rate was dramatically increased in the ≥15 oocytes group (6.9%) when compared to that in the 10–14 oocytes group (0.8%), while the cumulative LBR only increased 5.8% (from 83.4 to 89.2%).

Conclusions

The ideal number of oocytes retrieved in women aged 35–40 years is 10–14 oocytes, which achieves a high cumulative LBR while maintaining an acceptable low OHSS rate.
Literatur
2.
Zurück zum Zitat van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE (2006) Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 13(4):476–480CrossRefPubMed van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE (2006) Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 13(4):476–480CrossRefPubMed
3.
Zurück zum Zitat Chen YH, Xu XH, Wang Q, Zhang SD, Jiang LL, Zhang CL, Ge ZJ (2015) Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study. J Assist Reprod Genet 32(10):1459–1467. doi:10.1007/s10815-015-0571-6 CrossRefPubMedPubMedCentral Chen YH, Xu XH, Wang Q, Zhang SD, Jiang LL, Zhang CL, Ge ZJ (2015) Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study. J Assist Reprod Genet 32(10):1459–1467. doi:10.​1007/​s10815-015-0571-6 CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H (2016) Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod 31(2):370–376. doi:10.1093/humrep/dev316 PubMed Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H (2016) Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod 31(2):370–376. doi:10.​1093/​humrep/​dev316 PubMed
6.
Zurück zum Zitat Demko ZP, Simon AL, McCoy RC, Petrov DA, Rabinowitz M (2016) Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening. Fertil Steril 105(5):1307–1313. doi:10.1016/j.fertnstert.2016.01.025 CrossRefPubMed Demko ZP, Simon AL, McCoy RC, Petrov DA, Rabinowitz M (2016) Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening. Fertil Steril 105(5):1307–1313. doi:10.​1016/​j.​fertnstert.​2016.​01.​025 CrossRefPubMed
7.
Zurück zum Zitat Spandorfer SD, Chung PH, Kligman I, Liu HC, Davis OK, Rosenwaks Z (2000) An analysis of the effect of age on implantation rates. J Assist Reprod Genet 17(6):303–306CrossRefPubMedPubMedCentral Spandorfer SD, Chung PH, Kligman I, Liu HC, Davis OK, Rosenwaks Z (2000) An analysis of the effect of age on implantation rates. J Assist Reprod Genet 17(6):303–306CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Garrido N, Bellver J, Remohí J, Simón C, Pellicer A (2011) Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to measuring the likelihood of IVF success. Fertil Steril 96(1):40–46. doi:10.1016/j.fertnstert.2011.05.008 CrossRefPubMed Garrido N, Bellver J, Remohí J, Simón C, Pellicer A (2011) Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to measuring the likelihood of IVF success. Fertil Steril 96(1):40–46. doi:10.​1016/​j.​fertnstert.​2011.​05.​008 CrossRefPubMed
11.
Zurück zum Zitat Vuong TN, Phung HT, Ho MT (2015) Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial. Hum Reprod 30(5):1188–1195. doi:10.1093/humrep/dev038 CrossRefPubMed Vuong TN, Phung HT, Ho MT (2015) Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial. Hum Reprod 30(5):1188–1195. doi:10.​1093/​humrep/​dev038 CrossRefPubMed
12.
Zurück zum Zitat Ashrafi M, Bahmanabadi A, Akhond MR, Arabipoor A (2015) Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model. Arch Gynecol Obs 292(5):1145–1152. doi:10.1007/s00404-015-3723-0 CrossRef Ashrafi M, Bahmanabadi A, Akhond MR, Arabipoor A (2015) Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model. Arch Gynecol Obs 292(5):1145–1152. doi:10.​1007/​s00404-015-3723-0 CrossRef
14.
Zurück zum Zitat Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44(6):430–440CrossRefPubMed Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44(6):430–440CrossRefPubMed
15.
17.
Zurück zum Zitat Van Landuyt L, Verpoest W, Verheyen G, De Vos A, Van de Velde H, Liebaers I (2011) Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles. Hum Reprod 26(2):316–322. doi:10.1093/humrep/deq338 CrossRefPubMed Van Landuyt L, Verpoest W, Verheyen G, De Vos A, Van de Velde H, Liebaers I (2011) Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles. Hum Reprod 26(2):316–322. doi:10.​1093/​humrep/​deq338 CrossRefPubMed
18.
Zurück zum Zitat Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26(6):1270–1283. doi:10.1093/humrep/der037 CrossRef Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26(6):1270–1283. doi:10.​1093/​humrep/​der037 CrossRef
19.
Zurück zum Zitat Abuzeid MI, Bolonduro O, La Chance J, Abozaid T, Urich M, Ullah K, Ali T, Ashraf M, Khan I (2014) Cumulative live birth rate and assisted reproduction: impact of female age and transfer day. Facts Views Vis Obgyn. 6(3):145–149PubMedPubMedCentral Abuzeid MI, Bolonduro O, La Chance J, Abozaid T, Urich M, Ullah K, Ali T, Ashraf M, Khan I (2014) Cumulative live birth rate and assisted reproduction: impact of female age and transfer day. Facts Views Vis Obgyn. 6(3):145–149PubMedPubMedCentral
20.
Zurück zum Zitat Wu CH, Lee TH, Chen HH, Chen CI, Huang CC, Lee MS (2015) The influence of female age on the cumulative live-birth rate of fresh cycles and subsequent frozen cycles using vitrified blastocysts in hyper-responders. Taiwan J Obstet Gynecol 54(5):567–571. doi:10.1016/j.tjog.2015.08.009 CrossRefPubMed Wu CH, Lee TH, Chen HH, Chen CI, Huang CC, Lee MS (2015) The influence of female age on the cumulative live-birth rate of fresh cycles and subsequent frozen cycles using vitrified blastocysts in hyper-responders. Taiwan J Obstet Gynecol 54(5):567–571. doi:10.​1016/​j.​tjog.​2015.​08.​009 CrossRefPubMed
21.
Zurück zum Zitat Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A (2017) Cumulative live birth rates after one ART cycle including all subsequent frozen–thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod 32(3):556–567. doi:10.1093/humrep/dew358 PubMed Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A (2017) Cumulative live birth rates after one ART cycle including all subsequent frozen–thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod 32(3):556–567. doi:10.​1093/​humrep/​dew358 PubMed
22.
Zurück zum Zitat De Vos A, Van Landuyt L, Santos-Ribeiro S, Camus M, Van de Velde H, Tournaye H, Verheyen G (2016) Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. Hum Reprod 31(11):2442–2449. doi:10.1093/humrep/dew219 CrossRefPubMed De Vos A, Van Landuyt L, Santos-Ribeiro S, Camus M, Van de Velde H, Tournaye H, Verheyen G (2016) Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. Hum Reprod 31(11):2442–2449. doi:10.​1093/​humrep/​dew219 CrossRefPubMed
24.
Zurück zum Zitat Sunkara SK, Khalaf Y, Maheshwari A, Seed P, Coomarasamy A (2014) Association between response to ovarian stimulation and miscarriage following IVF: an analysis of 124 351 IVF pregnancies. Hum Reprod 29(6):1218–1224. doi:10.1093/humrep/deu053 CrossRefPubMed Sunkara SK, Khalaf Y, Maheshwari A, Seed P, Coomarasamy A (2014) Association between response to ovarian stimulation and miscarriage following IVF: an analysis of 124 351 IVF pregnancies. Hum Reprod 29(6):1218–1224. doi:10.​1093/​humrep/​deu053 CrossRefPubMed
25.
Zurück zum Zitat Tigges J, Godehardt E, Soepenberg T, Maxrath B, Friol K, Gnoth C (2016) Determinants of cumulative ART live-birth rates in a single-center study: age, fertilization modality, and first-cycle outcome. Arch Gynecol Obstet 294(5):1081–1089. doi:10.1007/s00404-016-4162-2 CrossRefPubMed Tigges J, Godehardt E, Soepenberg T, Maxrath B, Friol K, Gnoth C (2016) Determinants of cumulative ART live-birth rates in a single-center study: age, fertilization modality, and first-cycle outcome. Arch Gynecol Obstet 294(5):1081–1089. doi:10.​1007/​s00404-016-4162-2 CrossRefPubMed
26.
Zurück zum Zitat Du XF, Yang XH, Li J, Hao M, Guo YH (2016) Growth hormone co-treatment within a GnRH agonist long protocol improves implantation and pregnancy rates in patients undergoing IVF-ET. Arch Gynecol Obstet 294(4):877–883. doi:10.1007/s00404-016-4163-1 CrossRefPubMed Du XF, Yang XH, Li J, Hao M, Guo YH (2016) Growth hormone co-treatment within a GnRH agonist long protocol improves implantation and pregnancy rates in patients undergoing IVF-ET. Arch Gynecol Obstet 294(4):877–883. doi:10.​1007/​s00404-016-4163-1 CrossRefPubMed
27.
Zurück zum Zitat Tannus S, Turki R, Cohen Y, Son WY, Shavit T, Dahan MH (2017) Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35–40 years. Fertil Steril 107(6):1323–1328.e2. doi:10.1016/j.fertnstert.2017.04.014 Tannus S, Turki R, Cohen Y, Son WY, Shavit T, Dahan MH (2017) Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35–40 years. Fertil Steril 107(6):1323–1328.e2. doi:10.​1016/​j.​fertnstert.​2017.​04.​014
28.
Zurück zum Zitat Vlaisavljević V, Kovačič B, Knez J (2017) Cumulative live birth rate after GnRH agonist trigger and elective cryopreservation of all embryos in high responders. Reprod Biomed Online S1472–6483(17):30151–30157. doi:10.1016/j.rbmo.2017.03.017 Vlaisavljević V, Kovačič B, Knez J (2017) Cumulative live birth rate after GnRH agonist trigger and elective cryopreservation of all embryos in high responders. Reprod Biomed Online S1472–6483(17):30151–30157. doi:10.​1016/​j.​rbmo.​2017.​03.​017
29.
Zurück zum Zitat Verwoerd GR, Mathews T, Brinsden PR (2008) Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS. Reprod Biomed Online 17(3):312–317CrossRefPubMed Verwoerd GR, Mathews T, Brinsden PR (2008) Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS. Reprod Biomed Online 17(3):312–317CrossRefPubMed
30.
Zurück zum Zitat Reljic M, Vlaisavljević V, Gavrić V, Kovacic B (1999) Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome. J Reprod Med 44(8):713–718PubMed Reljic M, Vlaisavljević V, Gavrić V, Kovacic B (1999) Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome. J Reprod Med 44(8):713–718PubMed
31.
Metadaten
Titel
Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35–40 years undergoing long GnRH agonist IVF/ICSI cycles
verfasst von
Jianjun Zhou
Bin Wang
Yali Hu
Haixiang Sun
Publikationsdatum
06.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4503-9

Weitere Artikel der Ausgabe 5/2017

Archives of Gynecology and Obstetrics 5/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.